Comments*

 
  • Academy eBriefings

  • eBriefing

    Grantsmanship for Graduate Students and Postdocs: F30, F31, F32

    Featuring: Jaime S. Rubin (Columbia University)

    In this eBriefing, graduate students and postdocs can learn tips for concise and persuasive writing, a skill not only vital in academia, but essential for any career path.

    In this eBriefing

  • Recent eBriefings 

    February 22, 2017

    Grantsmanship for Graduate Students and Postdocs: F30, F31, F32

    Featuring: Jaime S. Rubin (Columbia University)

    In this eBriefing, graduate students and postdocs can learn tips for concise and persuasive writing, a skill not only vital in academia, but essential for any career path.

    February 10, 2017

    Advances in the Neurobiology of Mental Illness

    Speakers: Tyrone D. Cannon (Yale University), K. Ranga Rama Krishnan (Rush Medical College), Husseini Manji (Janssen Research & Development, LLC), Vaibhav Narayan (Janssen Research & Development, LLC), Daniel Pine (National Institute of Mental Health, US National Institutes of Mental Health), and B. Timothy Walsh (New York State Psychiatric Institute, Columbia University)

    Mental health disorders can cause debilitating consequences on quality of life for individuals, families, and society. The World Health Organization has reported that mental illnesses are the leading causes of disability worldwide. Depression alone accounts for one third of this disability.
     
    At this symposium, scientists, physicians, clinicians, other allied healthcare providers, policy makers, and patients across a range of scientific, clinical, industry, and government sectors explored new scientific understanding of the neurobiology (including genetics, neurocircuitry, and neuroimmune mechanisms) of a range of mental illnesses.

    February 7, 2017

    Aging and Nutrition: Novel Approaches and Techniques

    Speakers: Jan van Deursen (The Mayo Clinic), Vadim Gladyshev (Harvard University), Matt Kaeberlein (University of Washington), Vera Gorbunova (University of Rochester), Nicholas Stroustrup (Harvard University), and Arlan Richardson (University of Oklahoma)

    This eBriefing documents how prominent researchers in the field came together to explore the interplay between aging, nutrition, and metabolism, as well as the important role that novel technologies will play in current and future studies.

    January 26, 2017

    Big Data, Consumer Technology, and the Obesity Epidemic: Emerging Science and Ethical Considerations

    Organizers: Jason Block (Harvard Medical School), Matthew Harding (University of California Irvine), John G. Kral (SUNY Downstate Medical Center), Kristina H. Lewis (Wake Forest School of Medicine), Satchidananda Panda (SALK Institute), Gilles Bergeron (New York Academy of Sciences), and Mireille Mclean (New York Academy of Sciences)

    Researchers, health professionals, and a growing wellness-conscious public use technology to monitor health status. Big Data harnessed from this technology have created a foundation for focused research targeting obesity, but at what cost?

    January 18, 2017

    Antibiotics in Food: Can Less Do More?

    Organizers: Gary R. Acuff (Texas A&M University), Robert Brackett, (Illinois Institute of Technology), Sarah Marie Cahill (Food and Agriculture Organization of the United Nations), Bruce Cogill (Consultant), Jeffrey Farber (University of Guelph), Gilles Bergeron (The Sackler Institute for Nutrition Science), and Mireille Mclean (The Sackler Institute for Nutrition Science)

    Antibiotics have been used to prevent disease and accelerate growth in animal-rearing. Driven by concerns about antibiotic resistance, reduction in antibiotic use has changed the dynamics between food supply, food safety and public health. Concurrently, scientific advances offer alternative options such as probiotics and bacteriophages. This one-day conference reviewed the implications of antibiotic use in the food system from veterinary health, human health, food safety, and food system economic perspectives, addressing questions about how agricultural use contributes to antibiotic resistance in both humans and animals, the global landscape of antibiotic use in the food system, and viable alternatives.

    January 13, 2017

    Multiple Sclerosis: Diagnostic and Treatment Frontiers

    Keynote Speakers: Barry G. Arnason, MD (University of Chicago) and Giancarlo Comi, MD (Università Vita-Salute San Raffaele)

    Multiple sclerosis (MS) is a disease of the central nervous system that disrupts nerve impulses. Given the widespread prevalence and the disabling effects of this neurological condition, it is critical that diagnostics and treatments for MS continue to improve. This one-day, translational conference brought together academic and clinical researchers with industry leaders to discuss current therapeutics; diagnostic, prognostic, and predictive biomarkers; MRI usage in diagnosis and monitoring, and novel and emerging treatments.

    December 13, 2016

    The Addicted Brain: New Treatment Frontiers: Sixth Annual Aspen Brain Forum

    Keynote Speakers: The Honorable Patrick J. Kennedy (Former United States Representative, Rhode Island; Co-Founder, One Mind; and Founder, Kennedy Forum), George F. Koob (National Institute on Alcohol Abuse and Alcoholism, U.S. National Institutes of Health), and Nora D. Volkow (National Institute on Drug Abuse, U.S. National Institutes of Health)

    Leading experts, including NIAAA and NIDA directors, discuss the latest on neurobiology of addiction; susceptibility of the teen brain; new treatment strategies; and social, economic, political, and legislative aspects of this disease.

    December 12, 2016

    MicroRNAs: A Gene Silencing Mechanism with Therapeutic Implications

    Keynote Speaker: David Bartel (Whitehead Institute for Biomedical Research, Howard Hughes Medical Institute, MIT)

    MicroRNAs (miRNA) play critical roles in regulating gene expression. This symposium presented up-to-date basic, translational, and clinical research addressing the biology of miRNA and their promise as a therapeutic target.

    November 21, 2016

    Surgery and Cognition: Delirium, Cognitive Decline, and Opportunities to Protect the Brain

    Featuring: Sharon Inouye (Harvard Medical School)

    Surgery helps millions of Americans overcome illness to live longer, healthier lives. Yet surgery can lead to delirium, cognitive decline, and perhaps even a higher long-term risk of dementia for many patients, a risk that is poorly understood and often under-recognized in the clinic. With numerous factors—including age—contributing to each patient's level of risk, what are the challenges and opportunities to creating biomarkers and therapeutics for those who are most vulnerable?

    October 18, 2016

    HIV 2016: HIV and Non-Communicable Diseases

    Featured Speaker: Peter Godfrey-Faussett (UNAIDS)

    Participants gathered at the New York Academy of Sciences to discuss one of the next frontiers in the HIV field: how NCDs and HIV interact, how they should be treated, and how policy needs to adapt to facilitate effective treatment for people living with NCDs.

    October 3, 2016

    The Physics of Everything

    Is there a limit to human knowledge? Where do philosophy and physics intersect? Are we alone in the universe? Answering these and other questions, this six-part series united some of our most vibrant public intellectuals and communicators for explorations that reflect on the current state of modern physical sciences, its greatest mysteries and future endeavors, and its philosophical significance for our understanding of reality and the spiritual dimension of human existence.

    August 10, 2016

    Food–Microbiome Interaction: Implications for Health and Disease

    Keynote Speakers: John Bienenstock (McMaster University, Canada) and Jeffrey Gordon (Washington University in St. Louis)

    This eBriefing discusses the links between gut microbiota, diet, and health. It covers topics including the microbiome in development; microbiome interactions outside the gut; and the therapeutic potential of targeting the microbiome.

    July 8, 2016

    Sohn Conference: Pediatric Cancer in a Post-genomic World

    Keynote Speakers: Richard Gilbertson (Cambridge Cancer Centre, University of Cambridge, UK) and Craig B. Thompson (Memorial Sloan Kettering Cancer Center)

    This eBriefing covers the latest research on pediatric cancers, including topics such as etiological differences between pediatric and adult cancers, epigenetics, mechanisms of metastasis and disease recurrence, risk factors, diagnostics, and novel treatment approaches.

    July 7, 2016

    Epigenetics: Cancer and Beyond

    Organizers: Donald McCaffery (Resverlogix Corp.), Norman Wong (Resverlogix Corp.), Sarah Zapotichny (Resverlogix Corp.), George Zavoico (Jones Trading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
    Keynote Speaker: Craig B. Thompson (Memorial Sloan Kettering Cancer Center)

    Epigenetic abnormalities contribute to tumorigenesis and various diseases beyond cancer. This eBriefing describes recent progress in validating the therapeutic potential of small molecule inhibitors targeting epigenetic marks.

    July 6, 2016

    Disease Drivers of Aging: The 2016 Advances in Geroscience Summit

    Keynote Speakers: Richard Hodes (National Institute on Aging, NIH), Felipe Sierra (National Institute on Aging, NIH), Steven Austad (University of Alabama at Birmingham), and Elissa Epel (University of California, San Francisco)

    This eBriefing looks at how chronic diseases—specifically HIV/AIDS, diabetes, and cancer—affect aging, with a focus on the seven mechanistic pillars of aging.

    June 2, 2016

    Neuronal Connectivity in Brain Function and Disease

    Organizers: Thomas F. Franke (NYU School of Medicine), Eric Nestler (Icahn School of Medicine at Mount Sinai), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)

    Detailed understanding of neuronal connectivity promises unprecedented insights into the brain and its disorders and new options for diagnosis and therapy. This eBriefing explores work to map the brain and define its circuitry.

    May 26, 2016

    Advances in Human Microbiome Science: Gut–Brain Interaction

    Organizers: John Hambor (Boehringer Ingelheim), Sarkis Mazmanian (California Institute of Technology), Nilufer Seth (Pfizer), Erick Young (Boehringer Ingelheim), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)

    There is growing interest in the connection between gut microbiota and the central nervous system. This eBriefing discusses gut–brain interactions and the possibility of targeting the microbiome with a focus on CNS health.

    May 17, 2016

    Emerging Approaches to Cancer Immunotherapy

    Organizers: Renier Brentjens (Memorial Sloan Kettering Cancer Center), George Zavoico (Jones Trading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)

    Cancer immunotherapy, which engages the immune system to detect and destroy cancer cells, has gained popularity and success in recent years. This eBriefing features investigational approaches to better engineer or train the immune system to improve its responses, combat treatment resistance, and avoid adverse effects.

    May 13, 2016

    Editor's Guide to Writing and Publishing Your Paper

    Speaker: Brooke Grindlinger, Chief Scientific Officer, Scientific Programs & Blavatnik Awards (The New York Academy of Sciences)

    Publishing is critical to the scientific profession yet few opportunities exist for science PhDs to gain formal training in this area. A former editor for the Journal of Clinical Investigation provided an inside look into the editorial review process and how to present scientific results.

    April 26, 2016

    Regenerative Medicine: Transitioning Therapeutics from Cells to the Clinic

    Organizers: Jane S. Lebkowski (Asterias Biotherapeutics), George Zavoico (JonesTrading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)

    The field of regenerative medicine is burgeoning with cell-based therapies designed to enhance or correct cell function. This eBriefing considers efforts to rethink clinical, regulatory, and manufacturing approaches to accelerate the transition of these therapies to the clinic.